Northern Trust’s Athira Pharma ATHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.2K Hold
53,609
﹤0.01% 4353
2025
Q1
$15.3K Hold
53,609
﹤0.01% 4364
2024
Q4
$31.5K Hold
53,609
﹤0.01% 4330
2024
Q3
$23.9K Hold
53,609
﹤0.01% 4319
2024
Q2
$142K Buy
53,609
+389
+0.7% +$1.03K ﹤0.01% 3961
2024
Q1
$146K Sell
53,220
-1,040
-2% -$2.85K ﹤0.01% 3982
2023
Q4
$132K Sell
54,260
-258
-0.5% -$627 ﹤0.01% 4041
2023
Q3
$110K Sell
54,518
-2,900
-5% -$5.86K ﹤0.01% 3989
2023
Q2
$169K Sell
57,418
-223,221
-80% -$659K ﹤0.01% 3888
2023
Q1
$702K Buy
280,639
+5,987
+2% +$15K ﹤0.01% 3332
2022
Q4
$871K Sell
274,652
-1,641
-0.6% -$5.2K ﹤0.01% 3313
2022
Q3
$820K Sell
276,293
-3,751
-1% -$11.1K ﹤0.01% 3359
2022
Q2
$855K Buy
280,044
+3,672
+1% +$11.2K ﹤0.01% 3379
2022
Q1
$3.73M Sell
276,372
-12,315
-4% -$166K ﹤0.01% 2752
2021
Q4
$3.76M Sell
288,687
-385
-0.1% -$5.02K ﹤0.01% 2869
2021
Q3
$2.71M Buy
289,072
+188,287
+187% +$1.77M ﹤0.01% 3118
2021
Q2
$1.03M Sell
100,785
-51,800
-34% -$530K ﹤0.01% 3517
2021
Q1
$2.81M Buy
152,585
+7,278
+5% +$134K ﹤0.01% 3073
2020
Q4
$4.98M Buy
+145,307
New +$4.98M ﹤0.01% 2688